TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
+5.44%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$143M
AUM Growth
+$143M
(-29%)
Cap. Flow
-$3.79M
Cap. Flow
% of AUM
-2.65%
Top 10 Holdings %
Top 10 Hldgs %
99.77%
Holding
18
New
2
Increased
1
Reduced
1
Closed
1
Top Buys
| 1 |
MannKind Corp
MNKD
|
$5.57M |
| 2 |
Achieve Life Sciences
ACHV
|
$834K |
| 3 |
Opko Health
OPK
|
$94K |
Top Sells
| 1 |
Assertio
ASRT
|
$6.24M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$4.04M |
Sector Composition
| 1 | Healthcare | 34.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SLXP
1
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $27M | 18.87% | 300,000 | – | – |
|
|
MRTX
2
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $15.6M | 10.92% | 938,543 -242,857 | -21% | -$4.04M |
|
3
BioMarin Pharmaceuticals
BMRN
$11.2B
| $12.8M | 8.97% | 182,300 | – | – |
|
|
4
Achieve Life Sciences
ACHV
$152M
| $8.62M | 6.03% | 1,033,100 +100,000 | +11% | +$834K |
|
|
5
MannKind Corp
MNKD
$1.41B
| $5.57M | 3.89% | +1,070,419 | New | +$5.57M |
|
|
ECYT
6
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $4.97M | 3.48% | 465,763 | – | – |
|
|
SPHS
7
DELISTED
Sophiris Bio, Inc.
SPHS
| $1.85M | 1.29% | 500,000 | – | – |
|
|
DNDN
8
DELISTED
DENDREON CORPORATION
DNDN
| $238K | 0.17% | 79,600 | – | – |
|
|
9
Opko Health
OPK
$1.1B
| $94K | 0.07% | +11,195 | New | +$94K |
|
|
10
Assertio
ASRT
$80.4M
| – | – | -835,931 | Closed | -$6.24M |
|
|
AMBI
11
DELISTED
AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI
| $0 | ﹤0.01% | 46 | – | – |
|